US Broker Ratings

BeOne Medicines Ltd. (ONC) Stock Analysis: A 47% Upside Potential in Biotech Innovation

BeOne Medicines Ltd. (ONC), a burgeoning name in the biotechnology sector, is drawing significant attention from investors with its robust pipeline of oncology treatments and a compelling potential upside of..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring a 31.66% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands out in the biotechnology sector with its potent mix of innovation and financial resilience. As a leader in the healthcare industry, Regeneron has carved..

Repligen Corporation (RGEN) Stock Analysis: Exploring a 19.79% Potential Upside for Investors

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in the development and commercialization of bioprocessing technologies and systems. With a market capitalization of $8.29 billion, Repligen..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a 47.76% Potential Upside in Diagnostic Imaging

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, specifically in diagnostics and research, is capturing investor attention with a compelling potential upside of 47.76%. With a market..

Royalty Pharma (RPRX) Stock Analysis: Evaluating Its 5.37% Potential Upside and Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands as a unique player in the biotechnology sector, operating primarily as a buyer of biopharmaceutical royalties while funding innovation in the industry. Headquartered in..

Nuvalent, Inc. (NUVL) Stock Analysis: Navigating Its $9.77B Market Cap with Promising Cancer Therapies

Nuvalent, Inc. (NUVL), a clinical-stage biopharmaceutical company, has been making waves in the healthcare sector with its innovative approach to developing therapies for cancer patients. With a market capitalization of..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 101% Upside Potential with Strong Buy Ratings

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology industry, is capturing investor attention with its impressive potential upside of 101.14%. Operating within the healthcare sector, ADMA focuses..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Tightrope with Potential and Caution

Bio-Techne Corp (NASDAQ: TECH) is a significant player in the biotechnology sector, operating at the crossroads of healthcare and technology. With a market capitalization of $11.06 billion, this Minneapolis-based company..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring Growth Potential Amidst Notable Revenue Surge

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, has been capturing investor interest with its impressive market performance and innovative therapeutic solutions. With a market capitalization..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth with a $10.39 Billion Market Cap

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector specializing in diagnostics and research, is drawing attention with its impressive market cap of $10.39 billion...

Alkermes plc (ALKS) Stock Analysis: Navigating Growth Amidst a Potential -12.63% Downside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, has been attracting significant attention from investors with its robust lineup of pharmaceutical products targeting unmet medical needs. Despite..

Natera, Inc. (NTRA) Stock Analysis: A Leading Diagnostic Innovator with Robust Revenue Growth and Strong Buy Ratings

Investors with a keen eye on the healthcare sector may find Natera, Inc. (NASDAQ: NTRA) an intriguing opportunity. As a prominent player in the diagnostics and research industry, Natera is..

Zoetis Inc. (ZTS) Stock Analysis: Is a 62.96% Upside Worth the Investment?

For investors eyeing the healthcare sector, Zoetis Inc. (ZTS) presents a compelling opportunity with a significant potential upside of 62.96%, according to analyst ratings. With a market cap of $31.9..

West Pharmaceutical Services (WST) Stock Analysis: Strong Revenue Growth and Bullish Analyst Ratings Offer Promising Prospects

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector with a focus on medical instruments and supplies, has been capturing investor attention with its robust market..

Centene Corporation (CNC) Stock Analysis: Navigating the Healthcare Sector with a -5.93% Potential Downside

Centene Corporation (NYSE: CNC), a significant player in the healthcare plans industry, presents an intriguing case for investors navigating the dynamic healthcare sector. With a market capitalization of $32.46 billion,..

Guardant Health, Inc. (GH) Stock Analysis: Navigating High Growth in the Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is making waves in the healthcare sector with its cutting-edge diagnostic technologies. Headquartered in Palo Alto, California, this company is..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings Amid Impressive ROE and Expanding Diagnostic Portfolio

Lantheus Holdings, Inc. (NASDAQ: LNTH) presents an intriguing proposition for investors focused on the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With a market capitalization of..

Stevanato Group S.p.A. (STVN) Stock Analysis: Uncovering a 37% Upside Potential in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), an Italian stalwart in the healthcare sector, has captured investors’ attention with its promising growth potential, reflected in a striking 37.05% upside based on analysts’..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and Revenue Growth Propel Healthcare Giant Forward

Cardinal Health, Inc. (NYSE: CAH), a titan in the healthcare sector, operates primarily in the medical distribution industry. With a market capitalization of $55.72 billion, the company has established itself..

Insulet Corporation (PODD) Stock Analysis: Impressive Growth Potential with a 51.82% Upside

Insulet Corporation (NASDAQ: PODD), a leader in the healthcare sector specializing in medical devices, is making waves with its innovative insulin delivery systems. With a market capitalization of $10.96 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds